Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways

被引:138
作者
Feuerstein, GZ [1 ]
Young, PR [1 ]
机构
[1] Dupont Merck Pharmaceut Co, Cardiovasc Dis Res, Wilmington, DE 19880 USA
关键词
heart failure; protein kinases; signal transduction;
D O I
10.1016/S0008-6363(99)00372-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apoptosis is a form of cell death that involves discrete genetic and molecular programs, de novo protein expression and a unique cellular phenotype. Evidence for the existence of apoptosis in the human heart has been reported in various cardiac diseases, including ischemic and non-ischemic heart failure, myocardial infarction and arrhythmias. Among the most potent stimuli that elicit cardiomyocyte apoptosis are: oxygen radicals (including NO), cytokines (FAS/TNF alpha-receptor signaling), stress conditions (chemical or physical, e.g., radiation), sphingolipid metabolites (ceramide) and autocoids, e.g., angiotensin II. Apoptosis of cardiac myocytes may contribute to progressive pump-failure, arrhythmias and cardiac remodeling. The recognition of numerous molecular targets associated with cardiomyocyte apoptosis may provide novel therapeutic strategies for diverse cardiac ailments, as recently suggested by pharmacologic studies in experimental animals. This review paper is aimed to highlight the role of protein kinase signaling pathways in apoptosis with special attention to the stress-activated protein kinases (SAPK) and mitogen-activated protein kinases ( MAPK) systems. (C) 2000 Elsevier Science B.V. AII rights reserved.
引用
收藏
页码:560 / 569
页数:10
相关论文
共 65 条
  • [1] Enhanced Gαq signaling:: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
    Adams, JW
    Sakata, Y
    Davis, MG
    Sah, VP
    Wang, YB
    Liggett, SB
    Chien, KR
    Brown, JH
    Dorn, GW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) : 10140 - 10145
  • [2] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [3] Anversa P, 1998, LAB INVEST, V78, P767
  • [4] Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat
    Black, SC
    Huang, JQ
    Rezaiefar, P
    Radinovic, S
    Eberhart, A
    Nicholson, DW
    Rodger, IW
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (04) : 733 - 742
  • [5] Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart - p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion
    Bogoyevitch, MA
    GillespieBrown, J
    Ketterman, AJ
    Fuller, SJ
    BenLevy, R
    Ashworth, A
    Marshall, CJ
    Sugden, PH
    [J]. CIRCULATION RESEARCH, 1996, 79 (02) : 162 - 173
  • [6] Cascino I, 1996, J IMMUNOL, V156, P13
  • [8] SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1
    CUENDA, A
    ROUSE, J
    DOZA, YN
    MEIER, R
    COHEN, P
    GALLAGHER, TF
    YOUNG, PR
    LEE, JC
    [J]. FEBS LETTERS, 1995, 364 (02) : 229 - 233
  • [9] Transgenic G alpha q overexpression induces cardiac contractile failure in mice
    DAngelo, DD
    Sakata, Y
    Lorenz, JN
    Boivin, GP
    Walsh, RA
    Liggett, SB
    Dorn, GW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) : 8121 - 8126
  • [10] p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes
    Dean, JLE
    Brook, M
    Clark, AR
    Saklatvala, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (01) : 264 - 269